Avoid Errors With Wegovy During Transitions of Care

August 2021

You may see patients admitted on Wegovy, a new injectable for weight loss.

But it's not a new drug. It's semaglutide...the same "GLP-1 agonist" in injectable Ozempic or oral Rybelsus for type 2 diabetes.

Think of Wegovy as an alternative to Saxenda (liraglutide), the other injectable GLP-1 agonist approved for obesity.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Compounding Maximize IV Workflow System Benefits
High-Alert Meds Ensure Safety With IV Potassium Chloride
COVID-19 Know the Latest About COVID-19 Monoclonal Antibodies
Communication Be Ready to Help Patients Who Are Deaf or Hard of Hearing
COVID-19 Expect to Dispense Tocilizumab for COVID-19 Under an EUA
Transdermal Patches Ramp Up Transdermal Patch Safety
Alzheimer's Disease Anticipate Debate About Aducanumab for Alzheimer's Disease
Obesity & Weight Loss Avoid Errors With Wegovy During Transitions of Care
Migraine Rimegepant Is Now Approved for Migraine Prevention